Djokovic Owned Biotech Firm Aims To Prevent COVID Virus From Infecting Human Cells Using Peptide Therapy
Quite the controversial figure at present, Novak Djokovic owns 80% stake in a Biotech firm QuantBioRes working on the cure for COVID. Centered in Copenhagen, the company is working on a peptide therapy for Covid-19 that will prevent the virus from infecting human cells.